Sep 30, 2022

PROCEPT BioRobotics Q3 2022 Earnings Report

Reported strong third quarter results driven by increased U.S. revenues and system sales, and increased fiscal year 2022 total revenue guidance.

Key Takeaways

PROCEPT BioRobotics reported a strong third quarter with total revenue of $20.3 million, a 135% increase compared to the prior year period. The company increased its fiscal year 2022 total revenue guidance to approximately $72.5 million, representing 110% growth compared to 2021.

Total Revenue of $20.3 million for the third quarter of 2022, an increase of 135% compared to the prior year period

U.S. system and rental revenue of $9.8 million for the third quarter of 2022, an increase of 95% compared to the prior year period

U.S. handpiece and consumables revenue of $8.0 million for the third quarter of 2022, an increase of 267% compared to the prior year period

Increased fiscal year 2022 total revenue guidance to approximately $72.5 million, representing growth of 110% compared to 2021

Total Revenue
$20.3M
Previous year: $8.67M
+134.8%
EPS
-$0.51
Previous year: -$1.22
-58.2%
Gross Margin
50%
Previous year: 48.9%
+2.2%
Installed Base (US)
139
Previous year: 75
+85.3%
Gross Profit
$10.2M
Previous year: $4.24M
+141.3%
Cash and Equivalents
$249M
Previous year: $320M
-22.2%
Free Cash Flow
-$21.4M
Previous year: -$12.9M
+66.1%
Total Assets
$324M
Previous year: $351M
-7.8%

PROCEPT BioRobotics

PROCEPT BioRobotics

PROCEPT BioRobotics Revenue by Segment

PROCEPT BioRobotics Revenue by Geographic Location

Forward Guidance

The Company projects revenue for the full year 2022 to be approximately $72.5 million, which represents 110% growth over the Company’s prior year revenue. The Company projects full year 2022 Gross Margin guidance to be in the range 50% to 51%.

Revenue & Expenses

Visualization of income flow from segment revenue to net income